Prevalence, clinical manifestations, etiology, and treatment of depressionin Parkinson's disease

Citation
Jr. Slaughter et al., Prevalence, clinical manifestations, etiology, and treatment of depressionin Parkinson's disease, J NEUROP CL, 13(2), 2001, pp. 187-196
Citations number
97
Categorie Soggetti
Neurology
Journal title
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
ISSN journal
08950172 → ACNP
Volume
13
Issue
2
Year of publication
2001
Pages
187 - 196
Database
ISI
SICI code
0895-0172(200121)13:2<187:PCMEAT>2.0.ZU;2-H
Abstract
To determine the extent to which depression complicates Parkinson's disease (PD), the authors analyzed the literature on depression in PD in order to report on its prevalence, clinical manifestations, and treatment. By means of MEDLINE literature searches, the analysis focused on 45 PD depression st udies conducted from 1922 through 1998. The results indicate that the preva lence of depression is 31% for all PD patients. The clinical manifestations of PD depression include apathy, psychomotor retardation, memory impairmen t, pessimism, irrationality, and suicidal ideation without suicidal behavio r. PD depression is effectively treated with a variety of antidepressants, most commonly at present the selective serotonin reuptake inhibitors. Anecd otal evidence supports the use of sertraline to treat PD depression.